Skip to main content
Home
Division of Cancer Prevention
Making cancer prevention possible
  • Home
  • Major Programs
    • Major Programs
    • Programs with Independent Websites
    • Cancer Prevention Fellowship Program (CPFP)
    • Early Detection Research Network (EDRN)
    • NCI Community Oncology Research Program (NCORP)
    • Programs with Webpages within This Site
    • Alliance of Glycobiologists for Cancer Research
    • Barrett's Esophagus Translational Research Network (BETRNet)
    • Cancer Prevention Clinical Trials Network (CP-CTNet)
    • Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT)
    • Cancer Screening Research Network (CSRN)
    • Cancer Treatment Tolerability Consortium
    • Consortium for Imaging and Biomarkers (CIB)
    • HIV/Cervical Cancer Prevention ‘CASCADE’ Clinical Trials Network
    • Liquid Biopsy Consortium
    • Lung Cancer Screening Image Library
    • Multi-Cancer Detection (MCD) Research
    • NCI Cervical Cancer ‘Last Mile’ Initiative
    • Pancreatic Cancer Detection Consortium (PCDC)
    • Phase 0/I/II Cancer Prevention Clinical Trials Program (Consortia)
    • PREVENT Cancer Preclinical Drug Development Program (PREVENT)
    • Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO)
    • Small Cell Lung Cancer (SCLC) Consortium
    • Supportive Care and Symptom Management
    • Translational and Basic Science Research in Early Lesions (TBEL) Program
    • Translational Liver Cancer (TLC) Consortium
    • US-Latin American-Caribbean HIV/HPV-Cancer Prevention Clinical Trials Network (ULACNet)
  • Research Groups
    • Research Groups
    • Biometry
    • Breast and Gynecologic Cancer
    • Cancer Biomarkers
    • Chemopreventive Agent Development
    • Community Oncology and Prevention Trials
    • Early Detection
    • Gastrointestinal and Other Cancers
    • Lung and Upper Aerodigestive Cancer
    • Nutritional Science
    • Prostate and Urologic Cancer
  • Clinical Trials
    • Clinical Trials
    • Clinical Trials Search
    • Landmark Trials
    • Clinical Trials Management
    • Why I Joined a Clinical Trial
  • Funding & Grants
    • Funding & Grants
    • Funding Opportunities
    • Funded Grants
    • Grantsmanship Resources
  • Resources
    • Resources
    • Publication Search
    • Biorepositories
    • Cancer Data Access System (CDAS)
  • News & Events
    • News & Events
    • News
    • Blog
    • Meetings and Events
    • Videos and Webinars
    • Infographics
  • About DCP
    • About DCP
    • Scientific Scope
    • Director
    • DCP Leadership
    • History and Timeline
    • Staff Directory
  1. Home
  2. Major Programs
  3. Liquid Biopsy Consortium

Grants

PI Name PI Organization Title Grant Number Program Director
Agarwal, Ashutosh

University Of Miami School Of Medicine
United States

A comprehensive liquid biopsy platform for detection and prognostication in early stage breast cancer 5U01CA233363-05 Lynn Sorbara, Ph.D.
Papadopoulos, Nickolas

Johns Hopkins University
United States

Earlier Detection of Cancers using Non-Plasma Based Liquid Biopsies 5U01CA230691-05 Lynn Sorbara, Ph.D.
Patel, Abhijit

Yale University
United States

Lung Cancer Screening via Ultrasensitive and Cost-efficient Analysis of Tumor DNA Signatures in Blood 5U01CA233364-05 Lynn Sorbara, Ph.D.
Carter, Bob S

Massachusetts General Hospital
United States

Liquid Biopsy for treatment stratification of IDH1.R132H and EGFRvIII mutant gliomas 5U01CA230697-05 Lynn Sorbara, Ph.D.
Lee, Hakho

Massachusetts General Hospital
United States

Early Detection through Novel OCEAN Technology - Ovarian Cancer Exosomal Analysis with Nanoplasmonics 5U01CA233360-05 Lynn Sorbara, Ph.D.
Wong, David T

University Of California Los Angeles
United States

EFIRM-Liquid Biopsy (eLB): Ultrasensitive ctDNA and miRNA Detection for Early Assessment of Lung Cancer 5U01CA233370-05 Lynn Sorbara, Ph.D.
    • Liquid Biopsy Consortium
      • Pre-Application Webinar for RFA-CA-23-018 and RFA-CA-23-019
      • Symposium: “Charting the Course of Liquid Biopsy in Precision Prevention and Treatment”
      • Grants

FOLLOW US AT:

@NCIPrevention

@NCISymptomMgmt

@NCICastle

The National Cancer Institute

POLICIES

DCP Home

Contact DCP

Policies

Disclaimer Policy

Accessibility

FOIA

HHS Vulnerability Disclosure

NCI'S PDQ® EVIDENCE-BASED SUMMARIES

Cancer Prevention

Screening/Detection/Testing for Cancer

Supportive and Palliative Care

GENERAL INFORMATION

Cancer Prevention, Specific Cancers, Clinical Trials

Cancer Screening Topics For People Who Have No Symptoms

Managing The Side Effects of Cancer and Its Treatment

Coping With Cancer

US Preventive Services Task Force Recommendations About Cancer(link is external)

NIH COVID-19 Resources

U.S. Department of Health and Human Services  |  National Institutes of Health  |  National Cancer Institute  |  USA.gov

NIH…Turning Discovery Into Health®